Publicaciones en las que colabora con Felipe Santiago Fernández Vázquez (11)

2022

  1. Incidencia, morbimortalidad y tratamiento del síndrome coronario agudo durante el confinamiento por COVID-19

    REC: Interventional Cardiology, Vol. 4, Núm. 3, pp. 186-192

  2. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

  3. Temporal trend and potential impact of angiotensin receptor neprilysin inhibitors on transcatheter edge-to-edge mitral valve repair

    Revista Espanola de Cardiologia, Vol. 75, Núm. 12, pp. 1001-1010

2021

  1. Clinical and echocardiographic outcomes of transcatheter mitral valve repair in atrial functional mitral regurgitation

    International Journal of Cardiology, Vol. 345, pp. 29-35

  2. Percutaneous mitral valve repair: Outcome improvement with operator experience and a second-generation device

    Journal of Clinical Medicine, Vol. 10, Núm. 4, pp. 1-10

  3. Prognostic role of tapse to pasp ratio in patients undergoing mitraclip procedure

    Journal of Clinical Medicine, Vol. 10, Núm. 5, pp. 1-13

2020

  1. Acute Kidney Injury After Percutaneous Edge-to-Edge Mitral Repair

    Journal of the American College of Cardiology, Vol. 76, Núm. 21, pp. 2463-2473

  2. Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience

    Revista Espanola de Cardiologia, Vol. 73, Núm. 12, pp. 994-1002

  3. Transcatheter mitral repair according to the cause of mitral regurgitation: real-life data from the Spanish MitraClip registry

    Revista Espanola de Cardiologia, Vol. 73, Núm. 8, pp. 643-651

  4. Transcatheter mitral repair for functional mitral regurgitation according to left ventricular function: A real-life propensity-score matched study

    Journal of Clinical Medicine, Vol. 9, Núm. 6, pp. 1-14

2018

  1. No differences in levels of circulating progenitor endothelial cells or circulating endothelial cells among patients treated with ticagrelor compared with clopidogrel during non–ST-segment–elevation myocardial infarction

    Journal of the American Heart Association, Vol. 7, Núm. 19